Insider Cluster (2 insiders) ·Filed Aug 21, 2026

PTCT

PTC THERAPEUTICS, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago
Insider cluster: 2 insiders, $459K total
Actionable Insight • Neutral

This insider cluster is too small in dollar terms to warrant a trading signal. Monitor for any material insider buying (C-suite open-market purchases) or a significant increase in selling volume (>0.5% of market cap) before adjusting positioning. The stock's 81% analyst bullish consensus and strong institutional ownership suggest no near-term catalyst from insider activity.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
PTCT ▼ -6.53% at T+20d
NEUTRAL call ✗ call lost -6.53% · α vs SPY -6.00% · entry $69.82 → $65.26
Next anchor: T+60d in 6w
Latest observation: T+27 -5.01% FF3 residual α
Entry anchored
Aug 20, 04:00 PM ET
via 1-min bar
T+1d
+1.78%
call +1.78% · α +2.07%
$71.06
settled 6w ago
T+5d
+0.39%
call +0.39% · α -0.09%
$70.09
settled 5w ago
T+20d
-6.53%
call -6.53% · α -6.00%
$65.26
settled 14d ago
T+60d
—
call — · α —
—
in 6w

Price Chart

Loading chart...

Executive Summary

Two insiders at PTC Therapeutics sold a total of $459K in open-market sales over a 7-day window. Director Michael Schmertzler sold $389K and EVP/CLO Mark Boulding sold $71K, with Boulding also exercising options. The total value is only ~0.008% of PTCT's $5.9B market cap, making this a trivial cluster by proportionality standards. The sales are routine and non-informative — no bearish signal from this activity.

Key Financial Metrics

Direction
selling
Total Value
$459.0K
Insiders
2

Key Facts

  • Two insiders sold a combined $459K in open-market sales over 7 days
  • Director Michael Schmertzler sold $389K across multiple trades at ~$72
  • EVP/CLO Mark Boulding sold $71K after exercising options at $25.69
  • Total sales represent ~0.008% of PTCT's $5.9B market cap — trivial
  • No C-suite cluster buys or material insider conviction signal present

Financial Impact

Total insider sales of $459K, or ~0.008% of market cap — immaterial

insider ownership

Risk Factors

  • Insider selling could accelerate if management becomes less confident ahead of upcoming events
  • The cluster is too small to be predictive — false signal risk if extrapolated

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
81% bullish (21 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-PTCT-1787378564222
15 reports for PTCT
Performance horizon
100% Hit rate 4 of 4 directional calls best @ T+60▲ +19.01%Apr 28, 2026
Filters
Rows
Reports for PTCT — sortable, filterable
TypeNow
Aug 21, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$69.82 $65.26▼ −6.53%▼ −6.00%$63.46 (−9.11%)
Jul 16, 2026
11w ago
Press Release
BEARISH ★ 7/10
$78.52 $71.97▲ +8.34%▲ +11.96%$63.46 (+19.18%)
Jul 16, 2026
11w ago
Insider Cluster
NEUTRAL ★ 3/10
$78.52 $71.97▼ −8.34%▼ −11.96%$63.46 (−19.18%)
Jul 13, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$81.33 $74.63▼ −8.24%▼ −11.42%$63.46 (−21.97%)
Jul 8, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$88.57 $69.21▼ −21.86%▼ −25.13%$63.46 (−28.35%)
Jun 26, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$81.57 $76.82▼ −5.82%▼ −5.54%$63.46 (−22.20%)
Jun 16, 2026
15w ago
8-K
NEUTRAL ★ 5/10
$73.27 $78.06▲ +6.54%▲ +6.34%$63.46 (−13.39%)
Jun 9, 2026
16w ago
8-K
NEUTRAL ★ 2/10
$73.35 $89.55▲ +22.09%▲ +18.46%$63.46 (−13.48%)
May 19, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$71.02 $78.98▲ +11.21%▲ +10.47%$63.46 (−10.64%)
May 15, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$70.15 $73.27▲ +4.45%▲ +2.87%$63.46 (−9.54%)
Showing 10 of 15

US Market Status

Market Closed — Opens Mon (65h 8m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 22, 2026